Navigation Links
Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
Date:3/3/2009

Leaders in probiotics and artificial sweeteners partner to produce world's first probiotic-enhanced sweetener; collaboration promises to bring innovation to baking aisle

INDIANAPOLIS, March 3 /PRNewswire/ -- Ganeden Biotech, Inc. a Cleveland-based manufacturer of the patented probiotic strain GanedenBC30, today announced an exclusive partnership with Heartland Sweeteners, an Indianapolis-based leading innovator of health and wellness products and calorie-free sweeteners, to produce a new probiotic-enhanced sweetener.

The companies will work together in the coming months to develop a no-calorie artificial sweetener to be distributed nationally in retail grocers, including many already carrying Heartland Sweeteners' Nevella(R) line. The new sweetener can be used in a variety of traditional sweetener applications, as well as in baked goods as a healthy, no-calorie alternative.

"This collaboration marks a significant step forward in our effort to take probiotics beyond the yogurt aisle," said Andrew Lefkowitz, CEO of Ganeden Biotech. "We are partnering with Heartland Sweeteners to quickly bring to market an innovative product that can help support and maintain a healthy digestive system and boost immunity."

Heartland Sweeteners chose Ganeden Biotech's patented probiotic bacteria, GanedenBC30, because of its unique ability to survive manufacturing and baking temperatures and remain shelf stable. GanedenBC30's superior survivability can be attributed to its protection by an organic shell, which allows the bacteria to reach the digestive tract alive and in large numbers where it can provide the greatest benefits to consumers.

"By partnering with Ganeden Biotech, we can produce a sweetener that not only helps foods and beverages taste great, but also provides health benefits," said Michael Servie, President of Heartland Sweeteners. "Consumers now have an alternative to yogurts and dairy drinks and can now strengthen their body's defenses simply by adding this new product to their coffee, tea and baked goods."

The collaboration is the latest partnership between Ganeden Biotech and national manufacturers looking to bring digestive and immune health benefits to new product offerings. "In recent months Ganeden Biotech has partnered with several companies to expand probiotics products beyond the refrigerated section of the grocery store."

About Ganeden Biotech

Founded in 1997, Ganeden Biotech, Inc. is based in Cleveland, Ohio and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage(R) and Sustenex(TM) brands. It also licenses its patented probiotic bacteria, GanedenBC30, for use in commercial food and beverage applications, medical foods, nutraceuticals and in animal health industries. GanedenBC30 is self-affirmed GRAS (Generally Recognized As Safe) by an independent panel of experts assembled to assess its safety in use as a food ingredient. For more information about licensing, visit www.ganedenlabs.com. For probiotic supplement information, visit www.digestiveadvantage.com or www.sustenex.com.

About Heartland Sweeteners

Based in Indianapolis, Heartland Sweeteners, LLC., is a leader in the production and development of innovative food products that are great for the whole family. Heartland produces and distributes branded and private label sweeteners for the food industry. Their branded products of Nevella(R) and ideal(TM) are great for the whole family, diabetics and people watching their calorie intake. Both Nevella and ideal are great for baking and are distributed throughout North America and expanding into Europe, Central and South America. Visit Heartland at www.idealsweet.com and www.nevella.com.

    Contact:
    Russ Rizzo, Linhart PR
    303-951-2561
    rrizzo@linhartpr.com


'/>"/>
SOURCE Ganeden Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
2. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
3. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
4. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
5. Morningstar Healthcare Analysts to Discuss Top 15 Biotech Acquisition Targets on Wednesday, March 4 at 11 a.m. EST
6. PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprovas Enantiomers of DOTAP Chloride in Immunotherapies
7. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
8. Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development
9. DuPont Biotech Stewardship Program Gains External Certification
10. Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
11. Hong Kong Biotech Company, Filligent, Announces CE Certification of Its Revolutionary, Anti-Infective Medical Face Mask, the BioMask
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
(Date:3/18/2016)... 2016 --> --> ... Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & ... the border security market and the continuing migration crisis in ... Europe has led visiongain to publish this unique ... --> defence & security companies in the border ...
Breaking Biology News(10 mins):